185 related articles for article (PubMed ID: 32106718)
1. Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of p-glycoprotein and inhibition of ROS-mediated TNF-α/NF-κB pathways.
Hafez HM; Hassanein H
Drug Chem Toxicol; 2022 Mar; 45(2):548-559. PubMed ID: 32106718
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
[TBL] [Abstract][Full Text] [Related]
3. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
Khafaga AF; El-Sayed YS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
[TBL] [Abstract][Full Text] [Related]
4. Sinapic Acid Ameliorates Oxidative Stress, Inflammation, and Apoptosis in Acute Doxorubicin-Induced Cardiotoxicity via the NF-
Bin Jardan YA; Ansari MA; Raish M; Alkharfy KM; Ahad A; Al-Jenoobi FI; Haq N; Khan MR; Ahmad A
Biomed Res Int; 2020; 2020():3921796. PubMed ID: 32258120
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats.
Ibrahim Fouad G; Ahmed KA
Cardiovasc Toxicol; 2022 Feb; 22(2):152-166. PubMed ID: 34837640
[TBL] [Abstract][Full Text] [Related]
6. Dose-Dependent Cardioprotective Effect of Hemin in Doxorubicin-Induced Cardiotoxicity Via Nrf-2/HO-1 and TLR-5/NF-κB/TNF-α Signaling Pathways.
Refaie MMM; Shehata S; Ibrahim RA; Bayoumi AMA; Abdel-Gaber SA
Cardiovasc Toxicol; 2021 Dec; 21(12):1033-1044. PubMed ID: 34510376
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
8. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
9. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α.
Ma T; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
Mol Biol Rep; 2019 Feb; 46(1):105-118. PubMed ID: 30362071
[TBL] [Abstract][Full Text] [Related]
10. Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity.
El-Agamy DS; Ibrahim SRM; Ahmed N; Khoshhal S; Abo-Haded HM; Elkablawy MA; Aljuhani N; Mohamed GA
Int Immunopharmacol; 2019 Jul; 72():429-436. PubMed ID: 31030099
[TBL] [Abstract][Full Text] [Related]
11. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
[TBL] [Abstract][Full Text] [Related]
12. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
[TBL] [Abstract][Full Text] [Related]
13. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
El-Ela SRA; Zaghloul RA; Eissa LA
Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
Naderi Y; Khosraviani S; Nasiri S; Hajiaghaei F; Aali E; Jamialahmadi T; Banach M; Sahebkar A
Biomed Pharmacother; 2023 Feb; 158():114055. PubMed ID: 36495663
[TBL] [Abstract][Full Text] [Related]
15. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
16. Assessing the cardioprotective effect of necrosulfonamide in doxorubicin-induced cardiotoxicity in mice.
Abbas SF; Abdulkadim H; Hadi NR
J Med Life; 2023 Oct; 16(10):1468-1473. PubMed ID: 38313169
[TBL] [Abstract][Full Text] [Related]
17. β-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice.
Nazari Soltan Ahmad S; Sanajou D; Kalantary-Charvadeh A; Hosseini V; Roshangar L; Khojastehfard M; Haiaty S; Mesgari-Abbasi M
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):364-373. PubMed ID: 31630478
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells pretreated with platelet-rich plasma modulate doxorubicin-induced cardiotoxicity.
Zaki SM; Algaleel WA; Imam RA; Abdelmoaty MM
Hum Exp Toxicol; 2019 Jul; 38(7):857-874. PubMed ID: 30991846
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
Abbas NAT; Kabil SL
Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
